IP Library › Patent Application 19588039
Patent Application Utility PCT National Stage
App. No. 19/588,039 · Confirmation No. 8971

SEMIFLUORINATED ALKANE SMALL MOLECULE LFA-1 ANTAGONIST COMBINATION COMPOSITIONS FOR TREATMENT OF OCULAR DISORDERS

Application Undergoing Preexam Processing
⬇ PDF
 Code Description Pages PDF
2026-08-14 IDS.R197.REL ​Letter specifying the conditions for filing under 37 CFR 1.97​ 2 View
2026-08-14 IDS Information Disclosure Statement (IDS) Form (SB08) 6 View
2026-08-14 FOR Foreign Reference 22 View
2026-08-14 FOR Foreign Reference 27 View
2026-08-14 FOR Foreign Reference 54 View
2026-08-14 FOR Foreign Reference 191 View
2026-08-14 FOR Foreign Reference 13 View
2026-08-14 N417 Electronic Filing System Acknowledgment Receipt 3 View
2026-05-15 ABST Abstract — View
2026-05-15 IDS Information Disclosure Statement (IDS) Form (SB08) 5 View
2026-05-15 TRNA Transmittal of New Application 5 View
2026-05-15 ADS Application Data Sheet 9 View
2026-05-15 IDS.R197.REL ​Letter specifying the conditions for filing under 37 CFR 1.97​ 2 View
2026-05-15 ABST Abstract 2 View
2026-05-15 SPEC Specification 32 View
2026-05-15 CLM Claims 3 View
2026-05-15 DRW Drawings-only black and white line drawings 2 View
2026-05-15 N417 Electronic Filing System Acknowledgment Receipt 3 View
2026-05-15 N417.PYMT Electronic Fee Payment 2 View
2026-05-15 DRW.SUPP Drawings-black and white line and/or other drawings — View
2026-05-15 SCORE Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
19/588,039
Effective Filing
2026-05-15